TABLE 3.
ALOX15 | CLC | CYSLTR2 | HRH4 | SMPD3 | |
---|---|---|---|---|---|
Healthy controls | |||||
ALOX15 | 1 | 0.190 | 0.388* | 0.556* | 0.214 |
CLC | 0.190 | 1 | 0.090 | 0.340* | 0.245* |
CYSLTR2 | 0.388* | 0.090 | 1 | 0.438* | 0.342* |
HRH4 | 0.556* | 0.340* | 0.438* | 1 | 0.091 |
SMPD3 | 0.214 | 0.245* | 0.342* | 0.091 | 1 |
Asthma | |||||
ALOX15 | 1 | 0.635* | 0.755* | 0.859* | 0.423* |
CLC | 0.635* | 1 | 0.602* | 0.585* | 0.199 |
CYSLTR2 | 0.755* | 0.602* | 1 | 0.748* | 0.415* |
HRH4 | 0.859* | 0.585* | 0.748* | 1 | 0.355* |
SMPD3 | 0.423* | 0.199 | 0.415* | 0.355* | 1 |
Asthma+CRSwNP | |||||
ALOX15 | 1 | −0.071 | 0.468* | 0.491* | 0.368* |
CLC | −0.071 | 1 | 0.339 | 0.611* | 0.571* |
CYSLTR2 | 0.468* | 0.339 | 1 | 0.640* | 0.633* |
HRH4 | 0.491* | 0.611* | 0.640* | 1 | 0.780* |
SMPD3 | 0.368* | 0.571* | 0.633* | 0.780* | 1 |
N-ERD | |||||
ALOX15 | 1 | 0.209 | 0.459* | 0.242 | 0.393 |
CLC | 0.209 | 1 | 0.611* | 0.717* | 0.458* |
CYSLTR2 | 0.459* | 0.611* | 1 | 0.663* | 0.730* |
HRH4 | 0.242 | 0.717* | 0.663* | 1 | 0.314 |
SMPD3 | 0.393 | 0.458* | 0.730* | 0.314 | 1 |
Data presented as Pearson's correlation coefficients. Bolding indicates statistically significant values higher than 0.7. Grey shaded boxes are repeated values in the bivariate matrix. CRSwNP: chronic rhinosinusitis with nasal polyposis; N-ERD: nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. *: p<0.05.